PAVmed (PAVM) Net Cash Flow (2015 - 2025)

PAVmed's Net Cash Flow history runs 11 years deep, the most recent figure standing at -$1.5 million for Q4 2025.

• On a quarterly basis, Net Cash Flow fell 460.48% year-over-year to -$1.5 million in Q4 2025; TTM through Dec 2025 was $359000.0, a 94.28% decrease from a year earlier, with the FY2025 full-year figure at $359000.0, up 101.95% from the prior year.
• Net Cash Flow retreated to -$1.5 million in Q4 2025 per PAVM's latest filing, from -$905000.0 in the prior quarter.
• Across five years, Net Cash Flow topped out at $39.9 million in Q4 2021 and bottomed at -$17.0 million in Q4 2022.
• The 5-year median for Net Cash Flow is -$905000.0 (2025), against an average of $474842.1.
• Across the five-year window, Net Cash Flow slumped 3012.74% in 2023 and soared 3513.51% in 2025, its largest moves.
• Year by year, Net Cash Flow stood at $39.9 million in 2021, then plunged by 142.69% to -$17.0 million in 2022, then jumped by 60.28% to -$6.8 million in 2023, then soared by 106.2% to $420000.0 in 2024, then plunged by 460.48% to -$1.5 million in 2025.
• Per Business Quant, the three latest PAVM Net Cash Flow figures stand at -$1.5 million (Q4 2025), -$905000.0 (Q3 2025), and $1.3 million (Q2 2025).